Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: Effect on survival in patients with septic shock*
Ángel Crespo López(Hospital Universitario Infanta Cristina), Robert F. Grover(University of Colorado Boulder), Jan Bakker(Pontificia Universidad Católica de Chile), Michael Brockway(St. Johns Hospital), Steven H. Grossman(GlaxoSmithKline (Netherlands)), Jill Donaldson(GlaxoSmithKline (Netherlands)), José A. Lorente(Universidad de Granada), Jukka Takala(University of Bern), Antonio Anzueto, Sheila M. Willatts(Erasmus Hospital), Carl Arneson(GlaxoSmithKline (Netherlands)), Angela McLuckie(Guy's Hospital), Laurent Holzapfel(Servier (France)), G.Richard Grove(GlaxoSmithKline (Netherlands)), Michael Silverman(Lakeridge Health), Desmond P. Breen(Royal Hallamshire Hospital), Jay S. Steingrub(Response Biomedical (Canada))
Cited by 921
Related Papers
The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure
|Intensive Care Medicine|1996|11.7k
Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units
|Critical Care Medicine|1998|3.5k
Consensus on circulatory shock and hemodynamic monitoring. Task force of the European Society of Intensive Care Medicine
|Intensive Care Medicine|2014|1.8k
The use of maximum SOFA score to quantify organ dysfunction/failure in intensive care. Results of a prospective, multicentre study
|Intensive Care Medicine|1999|1.1k
Serial blood lactate levels can predict the development of multiple organ failure following septic shock
|The American Journal of Surgery|1996|857